Setting

Asia Pacific Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Country: COVID-19 Impact and Growth Opportunity

Published: 28 Nov 2020 | Report Code: 10247779 | Pages: 103

Asia Pacific virus filtration market will grow by 14.72% annually with a total addressable market cap of $8,116.1 million over 2020-2026 owing to the rapid growth of pharmaceutical and biotechnology industry, increasing investments in R&D, surging need for virus removal and clearance amid COVID-19 pandemic. Highlighted with 32 tables and 45 figures, this 103-page report “Asia Pacific Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Country: COVID-19 Impact and Growth Opportunity” is based on a holistic research of the entire Asia Pacific virus filtration market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific virus filtration market in every aspect of the classification from perspectives of Product, Application, End User, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section. Consumables Instruments • Filtration Systems • Chromatography systems Services Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section. Biological Applications • Vaccines and Therapeutics • Blood and Blood Products • Cellular and Gene Therapy Products • Tissue and Tissue Products • Stem Cell Products Medical Devices Water Purification Air Purification Other Applications Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section. • Pharmaceutical and Biotechnology Companies • Contract Research Organisations (CROs) • Academic & Research Institutes • Medical Device Companies • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific virus filtration market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Asahi Kasei Medical Co., Ltd. Charles River Laboratories International, Inc. Clean Cells General Electric Company Lonza Group AG Merck KGaA MilliporeSigma Pall Corporation Sartorius AG Thermo Fisher Scientific, Inc. Wuxi Apptec (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction 6 1.1 Industry Definition and Research Scope 6 1.1.1 Industry Definition 6 1.1.2 Research Scope 7 1.2 Research Methodology 10 1.2.1 Overview of Market Research Methodology 10 1.2.2 Market Assumption 11 1.2.3 Secondary Data 11 1.2.4 Primary Data 11 1.2.5 Data Filtration and Model Design 13 1.2.6 Market Size/Share Estimation 14 1.2.7 Research Limitations 15 1.3 Executive Summary 16 2 Market Overview and Dynamics 18 2.1 Market Size and Forecast 18 2.1.1 Impact of COVID-19 on World Economy 19 2.1.2 Impact of COVID-19 on the Market 22 2.2 Major Growth Drivers 24 2.3 Market Restraints and Challenges 27 2.4 Emerging Opportunities and Market Trends 30 2.5 Porter’s Fiver Forces Analysis 34 3 Segmentation of Asia Pacific Market by Product 38 3.1 Market Overview by Product 38 3.2 Consumables 40 3.3 Instruments 41 3.3.1 Filtration Systems 42 3.3.2 Chromatography systems 43 3.4 Services 44 4 Segmentation of Asia Pacific Market by Application 45 4.1 Market Overview by Application 45 4.2 Biological Applications 47 4.2.1 Vaccines and Therapeutics 49 4.2.2 Blood and Blood Products 50 4.2.3 Cellular and Gene Therapy Products 51 4.2.4 Tissue and Tissue Products 52 4.2.5 Stem Cell Products 53 4.3 Medical Devices 54 4.4 Water Purification 55 4.5 Air Purification 56 4.6 Other Applications 57 5 Segmentation of Asia Pacific Market by End User 58 5.1 Market Overview by End User 58 5.2 Pharmaceutical and Biotechnology Companies 60 5.3 Contract Research Organisations (CROs) 61 5.4 Academic & Research Institutes 62 5.5 Medical Device Companies 63 5.6 Other End Users 64 6 Asia-Pacific Market 2019-2026 by Country 65 6.1 Overview of Asia-Pacific Market 65 6.2 China 68 6.3 Japan 70 6.4 India 73 6.5 Australia 75 6.6 South Korea 77 6.7 Rest of APAC Region 79 7 Competitive Landscape 81 7.1 Overview of Key Vendors 81 7.2 New Product Launch, Partnership, Investment, and M&A 84 7.3 Company Profiles 85 Asahi Kasei Medical Co., Ltd. 85 Charles River Laboratories International, Inc. 87 Clean Cells 88 General Electric Company 89 Lonza Group AG 90 Merck KGaA 91 MilliporeSigma 92 Pall Corporation 93 Sartorius AG 94 Thermo Fisher Scientific, Inc. 95 Wuxi Apptec 96 8 Investing in Asia Pacific Market: Risk Assessment and Management 97 8.1 Risk Evaluation of Asia Pacific Market 97 8.2 Critical Success Factors (CSFs) 100 Related Reports and Products 103
List Of Tables

Table 1. Snapshot of Asia Pacific Virus Filtration Market in Balanced Perspective, 2019-2026 17 Table 2. Growth Rate of World Real GDP, 2017-2021 20 Table 3. Main Product Trends and Market Opportunities in Asia Pacific Virus Filtration Market 30 Table 4. Asia Pacific Virus Filtration Market by Product, 2016-2026, $ mn 38 Table 5. Asia Pacific Virus Filtration Market: Instruments by Technology, 2016-2026, $ mn 41 Table 6. Asia Pacific Virus Filtration Market by Application, 2016-2026, $ mn 45 Table 7. Asia Pacific Virus Filtration Market: Biological Applications by Segment, 2016-2026, $ mn 48 Table 8. Asia Pacific Virus Filtration Market by End User, 2016-2026, $ mn 58 Table 9. APAC Virus Filtration Market by Country, 2016-2026, $ mn 66 Table 10. China Virus Filtration Market by Product, 2016-2026, $ mn 69 Table 11. China Virus Filtration Market by Application, 2016-2026, $ mn 69 Table 12. China Virus Filtration Market by End User, 2016-2026, $ mn 69 Table 13. Japan Virus Filtration Market by Product, 2016-2026, $ mn 72 Table 14. Japan Virus Filtration Market by Application, 2016-2026, $ mn 72 Table 15. Japan Virus Filtration Market by End User, 2016-2026, $ mn 72 Table 16. India Virus Filtration Market by Product, 2016-2026, $ mn 74 Table 17. India Virus Filtration Market by Application, 2016-2026, $ mn 74 Table 18. India Virus Filtration Market by End User, 2016-2026, $ mn 74 Table 19. Australia Virus Filtration Market by Product, 2016-2026, $ mn 76 Table 20. Australia Virus Filtration Market by Application, 2016-2026, $ mn 76 Table 21. Australia Virus Filtration Market by End User, 2016-2026, $ mn 76 Table 22. South Korea Virus Filtration Market by Product, 2016-2026, $ mn 78 Table 23. South Korea Virus Filtration Market by Application, 2016-2026, $ mn 78 Table 24. South Korea Virus Filtration Market by End User, 2016-2026, $ mn 78 Table 25. Virus Filtration Market in Rest of APAC by Country, 2016-2026, $ mn 80 Table 26. Asahi Kasei Medical Co., Ltd.: Company Snapshot 85 Table 27. Asahi Kasei Medical Co., Ltd.: Business Segmentation 85 Table 28. Asahi Kasei Medical Co., Ltd.: Product Portfolio 86 Table 29. Asahi Kasei Medical Co., Ltd.: Revenue, 2016-2018, $ mn 86 Table 30. Asahi Kasei Medical Co., Ltd.: Recent Developments 86 Table 31. Risk Evaluation for Investing in Asia Pacific Market, 2019-2026 98 Table 32. Critical Success Factors and Key Takeaways 101
List Of Figures

Figure 1. Research Method Flow Chart 10 Figure 2. Breakdown of Primary Research 12 Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14 Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 16 Figure 5. Asia Pacific Virus Filtration Market, 2019-2026, $ mn 18 Figure 6. Impact of COVID-19 on Business 22 Figure 7. Primary Drivers and Impact Factors of Asia Pacific Virus Filtration Market 24 Figure 8. Primary Restraints and Impact Factors of Asia Pacific Virus Filtration Market 27 Figure 9. Investment Opportunity Analysis 31 Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Virus Filtration Market 34 Figure 11. Breakdown of Asia Pacific Virus Filtration Market by Product, 2019-2026, % of Revenue 38 Figure 12. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Product, Value ($ mn) and Share (%) 39 Figure 13. Asia Pacific Virus Filtration Market: Consumables, 2016-2026, $ mn 40 Figure 14. Asia Pacific Virus Filtration Market: Instruments, 2016-2026, $ mn 41 Figure 15. Asia Pacific Virus Filtration Market: Filtration Systems, 2016-2026, $ mn 42 Figure 16. Asia Pacific Virus Filtration Market: Chromatography systems, 2016-2026, $ mn 43 Figure 17. Asia Pacific Virus Filtration Market: Services, 2016-2026, $ mn 44 Figure 18. Breakdown of Asia Pacific Virus Filtration Market by Application, 2019-2026, % of Revenue 45 Figure 19. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 46 Figure 20. Asia Pacific Virus Filtration Market: Biological Applications, 2016-2026, $ mn 47 Figure 21. Asia Pacific Virus Filtration Market: Vaccines and Therapeutics, 2016-2026, $ mn 49 Figure 22. Asia Pacific Virus Filtration Market: Blood and Blood Products, 2016-2026, $ mn 50 Figure 23. Asia Pacific Virus Filtration Market: Cellular and Gene Therapy Products, 2016-2026, $ mn 51 Figure 24. Asia Pacific Virus Filtration Market: Tissue and Tissue Products, 2016-2026, $ mn 52 Figure 25. Asia Pacific Virus Filtration Market: Stem Cell Products, 2016-2026, $ mn 53 Figure 26. Asia Pacific Virus Filtration Market: Medical Devices, 2016-2026, $ mn 54 Figure 27. Asia Pacific Virus Filtration Market: Water Purification, 2016-2026, $ mn 55 Figure 28. Asia Pacific Virus Filtration Market: Air Purification, 2016-2026, $ mn 56 Figure 29. Asia Pacific Virus Filtration Market: Other Applications, 2016-2026, $ mn 57 Figure 30. Breakdown of Asia Pacific Virus Filtration Market by End User, 2019-2026, % of Revenue 59 Figure 31. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%) 59 Figure 32. Asia Pacific Virus Filtration Market: Pharmaceutical and Biotechnology Companies, 2016-2026, $ mn 60 Figure 33. Asia Pacific Virus Filtration Market: Contract Research Organisations (CROs), 2016-2026, $ mn 61 Figure 34. Asia Pacific Virus Filtration Market: Academic & Research Institutes, 2016-2026, $ mn 62 Figure 35. Asia Pacific Virus Filtration Market: Medical Device Companies, 2016-2026, $ mn 63 Figure 36. Asia Pacific Virus Filtration Market: Other End Users, 2016-2026, $ mn 64 Figure 37. Breakdown of APAC Virus Filtration Market by Country, 2019 and 2026, % of Revenue 66 Figure 38. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 67 Figure 39. Virus Filtration Market in China, 2016-2026, $ mn 68 Figure 40. Virus Filtration Market in Japan, 2016-2026, $ mn 71 Figure 41. Virus Filtration Market in India, 2016-2026, $ mn 73 Figure 42. Virus Filtration Market in Australia, 2016-2026, $ mn 75 Figure 43. Virus Filtration Market in South Korea, 2016-2026, $ mn 77 Figure 44. Virus Filtration Market in Rest of APAC, 2016-2026, $ mn 79 Figure 45. Growth Stage of Asia Pacific Virus Filtration Industry over the Forecast Period 81
Key Players (this may not be a complete list and extra companies can be added upon request): 
Asahi Kasei Medical Co., Ltd.	
Charles River Laboratories International, Inc.	
Clean Cells	
General Electric Company	
Lonza Group AG	
Merck KGaA	
MilliporeSigma	
Pall Corporation	
Sartorius AG	
Thermo Fisher Scientific, Inc.	
Wuxi Apptec